- Home
- ORGO vs ASIX Comparison
ORGO vs ASIX Comparison
Compare ORGO & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ASIX
- Stock Information
- Founded
- ORGO 1985
- ASIX 2016
- Country
- ORGO United States
- ASIX United States
- Employees
- ORGO N/A
- ASIX N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ASIX Major Chemicals
- Sector
- ORGO Health Care
- ASIX Industrials
- Exchange
- ORGO Nasdaq
- ASIX Nasdaq
- Market Cap
- ORGO 539.1M
- ASIX 526.1M
- IPO Year
- ORGO N/A
- ASIX N/A
- Fundamental
- Price
- ORGO $3.97
- ASIX $18.87
- Analyst Decision
- ORGO Buy
- ASIX Buy
- Analyst Count
- ORGO 3
- ASIX 1
- Target Price
- ORGO $7.33
- ASIX $32.00
- AVG Volume (30 Days)
- ORGO 717.2K
- ASIX 269.6K
- Earning Date
- ORGO 11-06-2025
- ASIX 11-07-2025
- Dividend Yield
- ORGO N/A
- ASIX 3.39%
- EPS Growth
- ORGO N/A
- ASIX 829.30
- EPS
- ORGO N/A
- ASIX 2.84
- Revenue
- ORGO $429,531,000.00
- ASIX $1,515,062,000.00
- Revenue This Year
- ORGO $2.51
- ASIX $4.71
- Revenue Next Year
- ORGO $25.45
- ASIX $4.59
- P/E Ratio
- ORGO N/A
- ASIX $6.64
- Revenue Growth
- ORGO N/A
- ASIX 1.31
- 52 Week Low
- ORGO $2.61
- ASIX $17.97
- 52 Week High
- ORGO $6.71
- ASIX $33.00
- Technical
- Relative Strength Index (RSI)
- ORGO 40.52
- ASIX 40.46
- Support Level
- ORGO $3.84
- ASIX $18.20
- Resistance Level
- ORGO $4.30
- ASIX $18.77
- Average True Range (ATR)
- ORGO 0.18
- ASIX 0.59
- MACD
- ORGO 0.00
- ASIX -0.09
- Stochastic Oscillator
- ORGO 23.64
- ASIX 29.45
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.